Core Insights - The Cooper Companies reported revenue of 964.7millionforthequarterendedJanuary2025,reflectingayear−over−yearincreaseof3.60.92, up from 0.85inthesamequarterlastyear,aligningwiththeconsensusEPSestimate[1]−ThereportedrevenuefellshortoftheZacksConsensusEstimateof981.48 million, resulting in a surprise of -1.71% [1] Financial Performance Metrics - The Cooper Companies' stock has returned -5.5% over the past month, underperforming the Zacks S&P 500 composite's -3.5% change, and currently holds a Zacks Rank 4 (Sell) [3] - Revenue by Geography: - Americas: 270.90million,exceedingtheaverageestimateof260.53 million, with a year-over-year change of +7.2% [4] - Asia Pacific: 128.70million,belowtheaverageestimateof138.64 million, representing a year-over-year change of -1.5% [4] - EMEA: 246.50million,belowtheaverageestimateof257.60 million, with a year-over-year change of +3.5% [4] - Revenue by Category: - CVI: 646.10million,slightlybelowtheaverageestimateof656.01 million, with a year-over-year change of +4% [4] - CSI: 318.60million,belowtheaverageestimateof326.91 million, reflecting a year-over-year change of +2.7% [4] - CSI- Office and surgical: 198.90million,slightlyabovetheaverageestimateof198.50 million, with a year-over-year change of +4.1% [4] - CSI- Fertility: 119.70million,belowtheaverageestimateof129.05 million, with a year-over-year change of +0.6% [4] - CVI- Sphere, other: 326.70million,belowtheaverageestimateof339.31 million [4] - CVI- Toric and multifocal: 319.40million,slightlyabovetheaverageestimateof318.23 million [4]